News

Our team was privileged to collaborate with Dr. Boheira El Geyoushi, Consultant Obstetrician, Gynecologist and Reproductive Health at Dr.Suleiman Al Habib’s Fertility Department, and to participate in the “Managing Infertility Together” health conference. With our recent launch of two new and unique Women’s Health products; Cerviron® and Neupausil®, Goro Healthcare is committed to partnering with our key customers to continue to improve access and awareness of vital medications that address under-treated female medical conditions in the region.

As part of our commitment to introducing novel therapies in Women’s Health to our region, Goro Healthcare is proud to announce the launch of Cerviron® vaginal ovules in the United Arab Emirates. Cerviron® is used to treat multiple gynecological indications, including vaginal infections, cervical erosions, vulvar itching and for pre and postoperative treatment in gynecological surgery.

We are also delighted to announce that Cerviron® has obtained reimbursement approval in

As part of Goro Healthcare’s key launch and customer engagement activities for Cerviron®, and upon the successful listing of the product in King’s College Hospital Dubai, we were privileged to hold a round table meeting with the members of the Gynecology Department at the hospital. The discussion was moderated by Dr. Aparna Devi Gumma, Consultant Obstetrician and Gynecologist and Head of Department, and was an incredible opportunity for us to collaborate with and learn from key opinion leaders

We are delighted to announce the UAE and Qatar launch of the Demophorius portfolio of CE approved sutures, blood bags, gloves and consumables, in collaboration with our distribution partner Cigalah. With this expansion of our commercialized portfolio, we look forward to continuing to deliver the broad range high quality medical solutions to our customers in both countries.

https://gorohealthcare.com/demophorius-healthcare/

Demophorius Healthcare is a world leading and award-winning provider of medical solutions that has been delivering high quality products via its worldwide distribution network for over

As part of our commitment to improving patient access to novel therapies in Women’s Health, Goro Healthcare is proud to announce its launch of Neopausil®, an innovative therapy to treat menopausal and peri-menopausal symptoms, including hot flashes, vaginal dryness and pain, as well as helping to counter depression and aging.

Neopausil® is a combination of natural ingredients (Resveratrol, Vitamin D and Vitamin E), proven to reduce menopausal symptoms, and shown to be as effective as hormone replacement therapy (HRT). Its patented technology, FM-LipoMATRIX, improves the bioavailability and distribution of its active ingredients. Neopausil is

We are proud to announce Goro Healthcare’s partnerships with four of the largest distributors in the Gulf (GCC) region; Cigalah Group, City Pharmacy, Avanzcare and Al-Safa Group. This step marks a critical milestone to activating Goro Healthcare’s best-in-class distribution platform in the Middle East and ensures that we are able to deliver on our commitment to be an efficient, end-to-end, single entry partner for international healthcare companies seeking to expand in our region.

Since starting business activities in 1911, Saudi Arabian firm, Cigalah Group, has partnered with a vast number of